China Approves ZEISS VISUMAX® 800 with SMILE® Pro, Elevating Laser Vision Correction Standards

ZEISS Medical Technology has received approval from China’s National Medical Products Administration (NMPA) for its VISUMAX® 800 femtosecond laser with SMILE® pro software, marking a significant advancement in laser vision correction for nearsightedness and astigmatism.

The next-generation laser system enhances surgical precision, offering faster treatment times and improved workflow efficiency. With over 10 million eyes treated globally, ZEISS continues to drive innovation in refractive surgery, expanding its impact across Asia, Europe, and the U.S.

"With growing demand for laser vision correction in China, VISUMAX 800 with SMILE pro delivers cutting-edge technology to optimize surgical outcomes for both patients and clinicians," said Maximilian Foerst, Head of ZEISS Greater China.

The system integrates AI-driven enhancements, including CentraLign® for precise centration, OcuLign® for cyclotorsion adjustment, and VISULYZE for real-time data analysis, ensuring an optimized surgical experience.

The approval strengthens ZEISS’ position as a leader in digital ophthalmic innovation, bringing greater accessibility and efficiency to China’s refractive surgery market.